Ventive Hospital H1FY27 Results (NSE: VENTIVE)
Signal: Steady quarter
The read
The H1 trajectory is a mixed operating recovery: revenue grew 9.8% to ₹10,939.47 million and commercial leasing outpaced hospitality, but employee costs grew 12.7%, depreciation grew 22.1%, and PAT growth to ₹1,241.82 million was materially assisted by a ₹1,022.40 million exceptional tax credit; the recent margin arc has therefore not yet confirmed a durable operating inflection.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,093.95 Cr | +9.8% | N/A |
| Net profit | ₹124.18 Cr | +93.3% | |
| EPS | ₹5.22 | +28.9% | |
| EBIT margin | N/A |
P&L walk
H1 revenue increased 9.8% to ₹10,939.47 million, with commercial leasing growth of 23.7% outpacing hospitality growth of 5.0%; EBITDA is not separately disclosed, while depreciation rose 22.1% and PAT increased 93.3% to ₹1,241.82 million, helped by the exceptional tax credit disclosed in the filing.
Segments
Commercial leasing is the main earnings driver: its revenue grew 23.7% to ₹2,475.05 million and segment result rose 2.0% to ₹2,052.82 million, versus hospitality revenue growth of 5.0% and a 6.5% decline in hospitality result to ₹377.65 million.
Key positives
- Commercial leasing revenue grew 23.7% YoY to ₹2,475.05 million, materially faster than consolidated revenue growth of 9.8%.
- Finance costs declined 6.2% YoY to ₹1,088.34 million despite ongoing investment and a larger operating platform.
- Operating cash flow was positive at ₹3,167.14 million for H1FY27, providing internal funding alongside the ₹5,560.39 million CWIP balance.
Key concerns
- Hospitality segment result declined 6.5% YoY to ₹377.65 million despite hospitality revenue growth of 5.0%, indicating weaker conversion of hotel revenue into segment profit.
- Reported PAT of ₹1,241.82 million includes an exceptional tax credit of ₹1,022.40 million, limiting the quality and repeatability of the 93.3% YoY profit growth.
- Employee costs grew 12.7% YoY versus revenue growth of 9.8%, while depreciation rose 22.1%, delaying operating-margin recovery.
Research and educational content only. Not investment advice.